GORDON CARL L - Insider Non-Derivative Transactions at Keros Therapeutics, Inc. (KROS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 13, 2024, GORDON CARL L's relationship to Keros Therapeutics, Inc. (KROS) is Director, and currently has 899,212 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KROS insiders.
Data Source: SEC.
GORDON CARL L - Insider Non-Derivative Transactions at KROS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 14, 2024 | Sell -- (Common Stock) | 29400 | 44.01 | 119522 |
| Aug 14, 2024 | Sell -- (Common Stock) | 220600 | 44.01 | 899212 |